Draft:Octavian Bucur

• Comment: There is no dates either. Put month/year date in. Hope that helps. scope_creep^Talk 18:45, 1 February 2026 (UTC)

• Comment: Please remove the patents. There are non-rs. No patent references on Wikipedia. I took out the Youtube vids. The guy is notable and doesn't need them. Please take a look at WP:REFB, a small tutorial to shows you how to do references. Ping me when your done. scope_creep^Talk 18:44, 1 February 2026 (UTC)

• Comment: Before you submit this for review please:
  * Read and apply what you learn in WP:REFB and WP:CITE
  * do the same with MOS:HEAD
  * All inline links should be removed, please, and turned into references if appropriate, Wikilinks, or external links in a section so named. See Wikipedia:External links. There should be no links pointing to external sources until those in the 'References' section (with the exception of one optional link in any infobox).
  * Note WP:NPROF and make sure your references verify that the criteria are passed
  There will be more to do, but these are the basics 🇵🇸‍🇺🇦 Fiddle^Timtrent Faddle^Talk to me 🇺🇦‍🇵🇸 21:51, 22 October 2025 (UTC)

Octavian Bucur is a Romanian-American scientist and the General Director of the Genomics Research and Development Institute (ICDG) in Bucharest, Romania.^[1][2][3] He is also an Associate Investigator at the Viron Molecular Medicine Institute in Boston, MA, USA^[4] and serves as the Romanian Representative to the 1+ Million Genomes European initiative (1+MG).^[2]

Early life and education

Bucur was born in Craiova, Romania in the Oltenia region. During secondary school, he participated in national competitions in physics and biology, including the Romanian National Olympiad of Physics (11th grade) and the National Olympiad of Biology (12th grade). Following an award at the National Biology Olympiad (Genetics),^[5] he received a scholarship to attend a university of his choice in Romania.^[6] On October 1st 1999, Bucur enrolled in the Carol Davila University of Medicine and Pharmacy in Bucharest. As a medical student, he collaborated with Dr. Mircea Leabu and Dr. Roxana Nat, publishing his first original scientific paper as the first author during his studies.^[7]

After receiving his M.D. degree, Bucur began a research fellowship at Harvard University and later completed a Ph.D. in Biology/Biochemistry at the Romanian Academy - Institute of Biochemistry, where he graduated with the highest distinction. His doctoral research was conducted at the Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, under supervision of Professors Stefana Petrescu, Roya Khosravi-Far and Prof. Alex Almasan. He subsequently trained as a postdoctoral fellow at the BIDMC, Harvard Medical School under Prof. Andrew H. Beck, focusing on molecular, digital, and computational pathology, with an emphasis on biomedical technology development and artificial intelligence (AI) applications in pathology. In 2017, he obtained a Certificate in Applied Biostatistics from the Harvard Clinical and Translational Science Center.^{[2][4][5][6][8][9]}

Over the following few years, Bucur held multiple academic and research appointments at Harvard University, including:

• Postdoctoral Fellow at BIDMC and Harvard Medical School;^[2]
• Instructor in Pathology, Harvard Medical School (2017–2018);^[2]
• Associate Member, Wyss Institute of Biologically Inspired Engineering, Harvard University (2014–2015, in the laboratory of Prof. George Church);^[4]
• Associate Member of the Ludwig Cancer Center at Harvard University (2016–2018);^[4]
• Affiliated researcher, Broad Institute of MIT and Harvard on Genomics, Boston (2016–2018).^[2][4]

Academic and professional Career

In October 2023, Bucur was elected as the General Director of the Genomics Research and Development Institute (ICDG) in Bucharest for a period of 3 years. Bucur has served as Romania's representative to the European 1+ Million Genomes Initiative from May 2023 and the European Infrastructure for Drug Repurposing (RePo4EU) from 2024. He was appointed as a Honorary Scientific Advisor to the Rector of the Carol Davila University of Medicine and Pharmacy, Prof. Viorel Jinga in 2023.^[1][2]

His professional background includes positions in academic institutions, research organizations, and biotechnology companies. He co-founded Viron Therapeutics LLC (now Porosome Therapeutics) in Boston, Massachusetts,^[10][11] where he served as chief executive officer. Bucur is also co-founder and editor-in-chief of Discoveries, a peer-reviewed biomedical journal indexed in PubMed and PubMedCentral (PMC), together with Prof. Elisa A. Liehn.^[12]

Research

Bucur's research has focused on molecular pathology, molecular oncology, spatial genomics, and biomedical technology development. Together with his collaborators from Harvard University and MIT, including Yongxin Zhao, Edward Boyden, and Andrew Beck, he is a main contributor to the development of Expansion Pathology, a method published in Nature Biotechnology (2017) and Nature Protocols (2020).^[8][9][13] The method involves the physical expansion of fixed tissue samples for improved pathology diagnostics, improving the resolution of conventional optical microscopy and enabling nanoscale imaging using standard equipment. Related technologies have been described in the context of pathology, spatial genomics, neuroscience, and molecular medicine.^{[2][13][14][15][16]}

At the Wyss Institute for Biologically Inspired Engineering at Harvard, Bucur collaborated in projects related to Fluorescence in Situ Sequencing (FISSEQ), a spatial genomics technique with applications in genomics and molecular biology.^[2][4]

As General Director of ICDG, Bucur has overseen the institute's development, including securing of and participation in several European genomic projects, including Genomic Data Infrastructure (GDI), Genome of Europe, Beyond 1 Million Genomes Plus (B1MG Plus) and EU4Health Joint Action - Personalized Cancer Medicine (JA PCM).^[2][4][8] Within the ROGEN project, initiated in December 2024, ICDG has the highest budget of approximately €18 million, to develop the Romanian national infrastructure for sequencing, genomics, computational genomics research, and to define the Romanian Reference Genome and perform studies of the diversity of Romanian population.^[17][18]

Honors and awards

Bucur has received numerous awards related to biomedical research and academic activity^[2][4], including:

• Recognition of Achievements in Translational and Basic Science Research, Harvard Medical School, Department of Pathology (2017)^[2]
• 10 Years of Pathology Research Award, Beth Israel Deaconess Medical Center (2017)^[2]
• Finalist, Harvard Medical PD Elevator Pitch Competition (2018)^[2]
• AACR–Millennium Pharmaceuticals Award, American Association for Cancer Research (2015)^[4]
• Lady Tata Memorial Trust International Award for Leukemia Research (2007–2008)^[4]
• AACR–Aflac Award, American Association for Cancer Research (2008)^[2]
• Leonardo da Vinci Research Fellowship, European Union (2004)^[2]
• IUBMB Travel Fellowship, Melbourne, Australia (2010)^[4]
• Romanian Government Research Fellowship (2003–2004)^[4]

In Romania, he received the Top Romanian Young Scientist Award (2023) from the Romanian Ministry of Research, Innovation, and Digitalization, during the Romanian Research Gala,^[19] as well as the Carol Davila Award for Accomplishment in Medicine (2023), presented by the Romanian Academy and MLNR.^[20]

References

Category:Romanian medical doctors Category:Romanian scientists Category:Genomics